November 27, 2024

NeoLight Awarded KIINDO™ Breakthrough Technology Agreement for Infant Care Capital Equipment with Premier, Inc.

Premier KIINDO Members Gain Access to NeoLight's Cutting-Edge Skylife Systems
Geometric shape

SCOTTSDALE, AZ – November 27, 2024 – NeoLight, a leading innovator in neonatal phototherapy, has been awarded a Breakthrough Technology group purchasing agreement for their Skylife Neonatal Phototherapy System with Premier, Inc. through its KIINDO™ pediatric performance group and collaborative. This new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for NeoLight’s cutting-edge Skylife Neonatal Phototherapy Systems.

Premier established KIINDO, a cohort of children’s hospitals, that seek to collaborate with innovative companies that manufacture technologies designed to help advance pediatric hospital outcomes. Additionally, KIINDO fosters clinical collaboration across the network of hospitals to help ensure high-quality products and best practices are accessible to their facilities.

NeoLight’s Skylife Neonatal Phototherapy Systems offer a superior treatment experience. Equipped with a 3D Light Array™ and Spectral Power Treatment™, Skylife delivers precise, targeted light therapy that exceeds American Academy of Pediatrics (AAP) guidelines. This innovative approach minimizes discomfort and maximizes effectiveness for both babies and caregivers, ensuring optimal treatment outcomes.

“We are thrilled to collaborate with Premier and offer our Skylife Neonatal Phototherapy Systems through their KIINDO program,” said Vivek Kopparthi, CEO of NeoLight. “This agreement will help us expand our reach and provide more healthcare providers with access to our breakthrough technology.”

MaryBeth Smith, Chief Commercial Officer at NeoLight, added, “Our agreement with Premier reflects our commitment to delivering innovative solutions that improve the lives of newborns. We look forward to working alongside Premier to enhance the quality of care provided by their members.”

This collaboration represents a significant step forward in neonatal care, emphasizing the importance of innovation and shared goals in the healthcare sector. By making advanced phototherapy solutions more accessible, NeoLight and Premier aim to transform the standard of care for newborns, ultimately leading to better health outcomes and brighter futures for infants and their families.

Premier is a leading technology-driven healthcare improvement company, providing solutions to two-thirds of all healthcare providers in the U.S. Playing a critical role in the rapidly evolving healthcare industry, Premier unites providers, suppliers, payers and policymakers to make healthcare better with national scale, smarter with actionable intelligence and faster with novel technologies. With integrated data and analytics, collaboratives, supply chain solutions, consulting and other services, Premier enables better care and outcomes at a lower cost.

###
NeoLight is a medical device company that develops empathy driven, best-in-class technologies for treating preventable conditions in the newborn care market. Empathy driven solutions are a framework that has the doctor-nurse-mother-infant ecosystem at the center. It fosters the emotional connection that happens, thereby providing not just treatment but also providing care. Driving neonatal care beyond the traditional hospital setting, NeoLight is also creating a robust home market to treat neonatal conditions in the home. To learn more, visit www.theneolight.com and follow us on Twitter and LinkedIn.